Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
- S-4 Registration of securities issued in business combination transactions
- 4.9 Exhibit 4.9
- 5.1 Exhibit 5.1
- 8.2 Exhibit 8.2
- 10.26 Exhibit 10.26
- 10.27 Exhibit 10.27
- 10.28 Exhibit 10.28
- 10.29 Exhibit 10.29
- 10.30 Exhibit 10.30
- 10.31 Exhibit 10.31
- 10.32 Exhibit 10.32
- 10.33 Exhibit 10.33
- 10.34 Exhibit 10.34
- 10.35 Exhibit 10.35
- 10.36 Exhibit 10.36
- 10.37 Exhibit 10.37
- 10.39 Exhibit 10.39
- 10.40 Exhibit 10.40
- 10.41 Exhibit 10.41
- 21.1 Exhibit 21.1
- 23.1 Exhibit 23.1
- 23.5 Exhibit 23.5
- 99.1 Exhibit 99.1
- 99.5 Exhibit 99.5
- 99.6 Exhibit 99.6
- 99.7 Exhibit 99.7
- 99.8 Exhibit 99.8
- 99.9 Exhibit 99.9
- 99.10 Exhibit 99.10
- Download Excel data file
- View Excel data file
Associated filings
- 5 Oct 20 EFFECT Notice of effectiveness
- 2 Oct 20 424B3 Prospectus supplement
- 30 Sep 20 S-4/A Registration of securities issued in business combination transactions (amended)
- 15 Sep 20 S-4/A Registration of securities issued in business combination transactions (amended)
- 27 Aug 20 S-4/A Registration of securities issued in business combination transactions (amended)
-
6 Jul 20 S-4 Registration of securities issued in business combination transactions
OCUP similar filings
- 30 Sep 20 Registration of securities issued in business combination transactions (amended)
- 15 Sep 20 Registration of securities issued in business combination transactions (amended)
- 27 Aug 20 Registration of securities issued in business combination transactions (amended)
- 6 Jul 20 Registration of securities issued in business combination transactions
Filing view
External links
Exhibit 99.9
July 6, 2020
Rexahn Pharmaceuticals, Inc.
15245 Shady Grove Road, Suite 455
Rockville, MD 20850
Consent to Reference in Proxy Statement/Prospectus/Information Statement
Rexahn Pharmaceuticals, Inc. (the “Company”) has filed the Registration Statement on Form S-4 with the Securities and Exchange Commission under the Securities Act of 1933, as amended (the “Securities Act”). In connection therewith, I hereby consent, pursuant to Rule 438 of the Securities Act, to the reference to me in the proxy statement/prospectus/information statement included in such registration statement as a future member of the board of directors of the Company.
Sincerely,
/s/ James Manuso | |
James Manuso |